MINDERA HEALTH™ ANNOUNCES COVERAGE WITH EVIDENCE PROJECT WITH HIGHMARK, INC. TO ADVANCE MODERATE-TO-SEVERE PSORIASIS PATIENT CARE AND REDUCE SPECIALTY DRUG SPENDING read more 04/11/23
Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients read more 10/20/22
Mountain Group Partners Completes Fundraising on $128 Million MGP Venture Fund III read more 06/28/22
TARGAN Secures $35M Series C Financing Led by Mountain Group Partners and NovaQuest Capital Management to Commercialize Novel Vaccine Delivery System for Poultry Industry read more 05/25/22
MINDERA HEALTH™ LAUNCHES PILOT WITH NATIONAL HEALTH INSURANCE COMPANY TO IMPROVE MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS PATIENTS THROUGH PRECISION MEDICINE read more 04/28/22
